ADMINISTRATION INTRAVESICALE D'APAZIQUONE APRES RESECTION TRANSURETHRALE POUR TRAITER LE CANCER
- 专利权人:
- SPECTRUM PHARMACEUTICALS; INC.
- 发明人:
- LENAZ, LUIGI,CHAWLA, SHANTA,BEER, MARIO
- 申请号：
- CA2680481
- 公开号：
- CA2680481C
- 申请日:
- 2008.03.13
- 申请国别(地区):
- CA
- 年份:
- 2016
- 代理人:
- 摘要：
- Bladder cancer treatments include the intravesical administration of apaziquone immediately (e.g. within about 6 hours) following transurethral resection.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- ADMINISTRATION OF INTRAVESICAL APAZIQUONE FOLLOWING TRANSURETRAL RESECTION FOR CANCER TREATMENT
- Intravesical apaziquone administration following transurethral resection for treating cancer
- Intravesical apadicone administration after transurethral resection to treat cancer
- INTRAVESICAL APAZIQUONE ADMINISTRATION FOLLOWING TRANSURETHRAL RESECTION
- Treatment of bladder cancer by topical administration of taxane particles
